Lynn Kirkpatrick
2021
In 2021, Lynn Kirkpatrick earned a total compensation of $288.1K as Chief Executive Officer at Ensysce Biosciences, a 85% increase compared to previous year.
Compensation breakdown
| Bonus | $114,000 |
|---|---|
| Salary | $174,149 |
| Total | $288,149 |
Kirkpatrick received $174.1K in salary, accounting for 60% of the total pay in 2021.
Kirkpatrick also received $114K in bonus.
Rankings
In 2021, Lynn Kirkpatrick's compensation ranked 11,664th out of 12,415 executives tracked by ExecPay. In other words, Kirkpatrick earned more than 6.0% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 11,664 out of 12,415 | 6th |
Division Manufacturing | 5,138 out of 5,505 | 7th |
Major group Chemicals And Allied Products | 2,264 out of 2,375 | 5th |
Industry group Drugs | 2,009 out of 2,096 | 4th |
Industry Pharmaceutical Preparations | 1,485 out of 1,546 | 4th |
Source: SEC filing on May 2, 2022.
Kirkpatrick's colleagues
We found two more compensation records of executives who worked with Lynn Kirkpatrick at Ensysce Biosciences in 2021.
News
Ensysce Biosciences CEO Lynn Kirkpatrick's 2023 pay slips 18% to $509K
October 17, 2024
Ensysce Biosciences CFO David Humphrey's 2022 pay jumps 175% to $781K
July 13, 2023
Ensysce Biosciences CEO Lynn Kirkpatrick's 2021 pay jumps 85% to $288K
May 2, 2022
Ensysce Biosciences CEO D Kirkpatrick receives $156K in 2020
December 17, 2021